Stay updated on Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial page.

Latest updates to the Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe Record History shows a new Revision: v3.3.2 entry. The previous Revision: v3.2.0 entry is removed.SummaryDifference0.1%

- Check26 days agoChange DetectedRemoved a government funding/operating status notice banner. The trial record history and study details remain unchanged.SummaryDifference0.7%

- Check41 days agoChange DetectedA new version on 2024-03-17 adds a recruitment status update. The history shows the study was terminated and will not proceed to Phase II, with prior status updates documented.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference12%

- Check77 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

- Check91 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No other substantive changes to core content or time-sensitive information.SummaryDifference0.7%

Stay in the know with updates to Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Bendamustine Prednisone in Refractory MM Clinical Trial page.